Effects of Remote Ischemic Conditioning on Hand Use in Individuals With Spinal Cord Injury and Amyotrophic Lateral Sclerosis
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03851302 |
Recruitment Status :
Active, not recruiting
First Posted : February 22, 2019
Last Update Posted : August 3, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Spinal Cord Injuries Amyotrophic Lateral Sclerosis | Other: Active Remote Ischemic Conditioning Other: Sham Remote Ischemic Conditioning Other: Isometric hand exercise | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 21 participants |
Allocation: | Randomized |
Intervention Model: | Crossover Assignment |
Masking: | Single (Participant) |
Primary Purpose: | Basic Science |
Official Title: | Effects of Remote Ischemic Conditioning on Hand Use in Individuals With Spinal Cord Injury and Amyotrophic Lateral Sclerosis: A Preliminary Study |
Actual Study Start Date : | October 28, 2019 |
Actual Primary Completion Date : | July 30, 2022 |
Estimated Study Completion Date : | September 30, 2022 |

Arm | Intervention/treatment |
---|---|
Experimental: Active RIC + isometric hand exercise
Subjects will receive an active remote ischemic conditioning (200mmHg cuff pressure) before an active isometric hand exercise.
|
Other: Active Remote Ischemic Conditioning
The active RIC protocol involves 5 cycles of 5-min inflation and 5-min deflation on the non-target arm. The active RIC will be achieved via blood pressure cuff inflation to 200 mmHg. Other: Isometric hand exercise Participants will be instructed to pinch a dynamometer with thumb and index finger at different intensities and durations. The intensities of pinch force will be 10%, 25%, and 50% of the maximal voluntary contraction (MVC). For each intensity, durations of 2, 4, and 6 s will be employed, which resulted in nine different combinations delivered in pseudorandom order. Participants will perform 2 sets of the isometric hand exercise (18 pinches in total). The interval between each pinch will be 2 seconds, with 30 second intervals between each set. |
Sham Comparator: Sham RIC + isometric hand exercise
Subjects will receive an sham remote ischemic conditioning (10 mmHg below the subjects' diastolic blood pressure) before an active isometric hand exercise.
|
Other: Sham Remote Ischemic Conditioning
The sham RIC protocol involves 5 cycles of 5-min inflation and 5-min deflation on the non-target arm. The sham RIC will be achieved via blood pressure cuff inflation to 10 mmHg below the subjects' diastolic blood pressure which would not cause the blood occlusion. Other: Isometric hand exercise Participants will be instructed to pinch a dynamometer with thumb and index finger at different intensities and durations. The intensities of pinch force will be 10%, 25%, and 50% of the maximal voluntary contraction (MVC). For each intensity, durations of 2, 4, and 6 s will be employed, which resulted in nine different combinations delivered in pseudorandom order. Participants will perform 2 sets of the isometric hand exercise (18 pinches in total). The interval between each pinch will be 2 seconds, with 30 second intervals between each set. |
- Changes of Electromyographic responses after RIC plus hand isometric exercise [ Time Frame: Change in peak-to-peak amplitude between baseline measurement and immediately after completion of RIC plus isometric hand exercise. ]Response to electrical and magnetic stimulation will be measured via peak-to-peak amplitude (millivolts) in abductor pollicis brevis and first dorsal interosseous muscles. The changes of the electromyographic responses will be measured immediately after active/sham RIC plus isometric hand exercise in comparison with baseline measurement. The purpose is to investigate the synergic effects of RIC on hand isometric exercise.
- Changes of Electromyographic responses after RIC but before hand isometric exercise [ Time Frame: Change in peak-to-peak amplitude between baseline measurement and immediately after completion of RIC. ]Response to electrical and magnetic stimulation will be measured via peak-to-peak amplitude (millivolts) in abductor pollicis brevis and first dorsal interosseous muscles. The changes of the electromyographic responses will be measured immediately after active/sham RIC but before isometric hand exercise in comparison with baseline measurement. The purpose is to investigate whether RIC alone could change electromyographic responses.
- Changes of Electromyographic responses 15 mins after RIC plus hand isometric exercise [ Time Frame: Change in peak-to-peak amplitude between immediately after completion of RIC plus isometric hand exercise and 15 mins after completion of RIC plus isometric hand exercise. ]Response to electrical and magnetic stimulation will be measured via peak-to-peak amplitude (millivolts) in abductor pollicis brevis and first dorsal interosseous muscles. The changes of the electromyographic responses will be measured 15 mins after active/sham RIC plus isometric hand exercise in comparison with the measurement immediately after active/sham RIC plus isometric hand exercise. The purpose is to investigate whether the changes of electromyographic responses would last 15 mins.
- Inflammatory mediators: the intensity of the gene expression of Toll-like receptor (TLR) signal pathway. [ Time Frame: Change in mediator level between baseline measurement and immediately after completion of RIC. ]The blood samples will be collected before and after RIC to analyze on the changes of inflammatory mediators on the intensity of the gene expression related to Toll-like receptor (TLR) signal pathway.
- Heart rate [ Time Frame: Change in averaged heart rate between inflation and deflation phase during active/sham RIC. ]The heart rate will be monitored in real time during RIC to ensure the stable hemodynamic responses toward the ischemic stimulation.
- Blood pressure [ Time Frame: Change in averaged blood pressure between inflation and deflation phase during active/sham RIC. ]The blood pressure (systolic and diastolic) will be monitored in real time during RIC to ensure the stable hemodynamic responses toward the ischemic stimulation.
- Oxygen saturation [ Time Frame: Change in averaged oxygen saturation between inflation and deflation phase during active/sham RIC. ]The oxygen saturation will be monitored in real time during RIC to ensure the stable hemodynamic responses toward the ischemic stimulation.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 75 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Able-bodied participants
- Age between 18 and 75 years;
- No known central or peripheral neurological disease or injury.
SCI participants
Inclusion Criteria:
- Age between 18 and 75 years;
- Chronic (more than 12 months since injury) motor-incomplete SCI between neurological levels C2-C8
- Detectable F-wave responses of the left or right abductor pollicis brevis (APB) to median nerve stimulation;
- Detectable motor evoked potentials in left or right APB muscles to transcranial magnetic stimulation;
- Able to perform thumb-middle finger opposition pinch task with detectable APB EMG muscle activity.
ALS participants
- Age between 21 and 75 years;
- Diagnosis of probable or definite ALS.
- Incomplete weakness of left or right wrist or hand muscles: score of 2, 3, or 4 (out of 5) on manual muscle testing of finger extension, finger flexion, or finger abduction.
- Detectable motor evoked potentials in left or right APB muscles to transcranial magnetic stimulation;
- Able to perform thumb-middle finger opposition pinch task with detectable APB EMG muscle activity.
Exclusion Criteria:
- Multiple spinal cord lesions;
- History of seizures;
- Use of medications that significantly lower seizure threshold, such as amphetamines and bupropion;
- History of implanted brain/spine/nerve stimulators, aneurysm clips, or cardiac pacemaker/defibrillator;
- Any extremity soft tissue, orthopedic, or vascular condition or injury that may contraindicate RLIC (uncontrolled hypertension, peripheral vascular disease, hematological disease, severe hepatic or renal dysfunction);
- Any other contraindication to undergoing magnetic resonance imaging (except for claustrophobia);
- Clinically significant infection of any kind (urinary tract, pulmonary, skin or other)
- Significant coronary artery or cardiac conduction disease;
- Open skin lesions over the neck, shoulders, or arms;
- Pregnancy
- Unsuitable for study participation as determined by study physician. In addition, a medical record review will be conducted to identify any other medical concerns that might increase the risks associated with participation.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03851302
United States, New York | |
James J. Peters VA Medical Center | |
Bronx, New York, United States, 10468 |
Principal Investigator: | Noam Y Harel, MD, PhD | James J. Peters VA Medical Center |
Responsible Party: | Noam Y. Harel, Principal Investigator, Bronx VA Medical Center |
ClinicalTrials.gov Identifier: | NCT03851302 |
Other Study ID Numbers: |
HAR-18-47 |
First Posted: | February 22, 2019 Key Record Dates |
Last Update Posted: | August 3, 2022 |
Last Verified: | August 2022 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Yes |
Plan Description: | A Limited Dataset (LDS) will be shared in electronic format pursuant to a VA-approved Data Use Agreement. Individually Identifiable Data will be shared pursuant to valid HIPAA Authorization, Informed Consent, and an appropriate written agreement limiting use of the data to the conditions as described in the authorization and consent, and a written assurance from the recipient that the information will be maintained in accordance with the security requirements of 38 CFR Part 1.466. |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Remote ischemic conditioning Neuroplasticity transcranial magnetic stimulation |
Spinal Cord Injuries Motor Neuron Disease Amyotrophic Lateral Sclerosis Sclerosis Wounds and Injuries Pathologic Processes Spinal Cord Diseases Central Nervous System Diseases |
Nervous System Diseases Trauma, Nervous System Neurodegenerative Diseases Neuromuscular Diseases TDP-43 Proteinopathies Proteostasis Deficiencies Metabolic Diseases |